Top

The journal of nutrition, health & aging

Published in:

28-04-2023 | Sarcopenia | Original Research

Effects of Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Older Adults with Sarcopenia: A Randomized, Double-Blind, Placebo-Controlled Study

Authors: C. Yang, Y. Song, T. Li, X. Chen, J. Zhou, Q. Pan, W. Jiang, M. Wang, Hong Jia

Published in: The journal of nutrition, health & aging | Issue 5/2023

Abstract

Objectives

Sarcopenia is recognized as a major public health concern because of its association with several adverse health events. Beta-hydroxy-beta-methylbutyrate (HMB) supplementation reportedly delays the loss of muscle mass and function; however, the effect of HMB on sarcopenia remains inconclusive. We aimed to evaluate the impact of HMB intervention on muscle strength, physical performance, body compositions, and inflammatory factors in older adults with sarcopenia.

Design

Randomized, double-blind, placebo-controlled trial.

Setting and Participants

This study included subjects aged ≥60 years with sarcopenia which were assigned to the HMB group (HMBG, n=18) and the placebo group (PG, n=16).

Intervention

The HMBG and PG were supplied with HMB and placebo products twice daily for 12 weeks, and both received resistance exercise training twice a week in 12 weeks.

Measurements

Hand grip strength was selected as the primary outcome; gait speed, five-time chair stand test, body composition and inflammatory indicators were selected as the secondary outcomes. The differences in changes from baseline between the two groups were analyzed using the analysis of covariance(ANCOVA).

Results

After the 12-week intervention, the HMBG demonstrated significantly greater improvements in handgrip strength (4.61(95%CI:2.93,6.28) kg, P<0.001), gait speed (0.11(95%CI:0.02,0.20)m/s, P=0.014), five-time chair stand test (−3.65 (95%CI:−5.72, −1.58)s, P=0.001), muscle quality (2.47(95%CI:1.15,3.80),kg·kg⁻¹ P=0.001) and tumor necrosis factorlike weak inducer of apoptosis (−15.23(95%CI:−29.80,−0.66)pmol/mL, P=0.041) compared with the PG; no significant differences in skeletal muscle mass, skeletal muscle index, and other body composition parameters were found between the two groups.

Conclusion

In older adults with sarcopenia, HMB significantly enhance the effect of resistance exercise training on muscle strength, physical performance, muscle quality, and reduced inflammatory factors. Therefore, HMB supplementation could be an effective treatment for sarcorpenia. The trial protocol was registered at http://www.chictr.org.cn/showproj.aspx?proj=47571 as ChiCTR2000028778.

Available only for authorised users

Phillips SM. (2015). Nutritional supplements in support of resistance exercise to counter age-related sarcopenia. Adv Nutr. 6(4):452–460. https://doi.org/10.3945/an.115.008367CrossRefPubMedPubMedCentral

Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, et al. (2020). Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 21(3):300–307.e2.https://doi.org/10.1016/j.jamda.2019.12.012CrossRefPubMed

Holecek M. (2017). Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions. J Cachexia Sarcopenia Muscle. 8(4):529–541. https://doi.org/10.1002/jcsm.12208CrossRefPubMedPubMedCentral

Wilson JM, Lowery RP, Joy JM, Andersen JC, Wilson SM, Stout JR, Duncan N, Fuller JC, Baier SM, Naimo MA, et al. (2014). The effects of 12 weeks of beta-hydroxy-beta-methylbutyrate free acid supplementation on muscle mass, strength, and power in resistance-trained individuals: a randomized, double-blind, placebo-controlled study. Eur J Appl Physiol. 114(6):1217–1227. https://doi.org/10.1007/s00421-014-2854-5CrossRefPubMedPubMedCentral

Rossi AP, D’Introno A, Rubele S, Caliari C, Gattazzo S, Zoico E, Mazzali G, Fantin F, Zamboni M. (2017). The Potential of β-Hydroxy-β-Methylbutyrate as a New Strategy for the Management of Sarcopenia and Sarcopenic Obesity. Drugs Aging. 34(11):833–840.https://doi.org/10.1007/s40266-017-0496-0CrossRefPubMed

Asadi A, Arazi H, Suzuki K. (2017). Effects of β-Hydroxy-β-methylbutyrate-free Acid Supplementation on Strength, Power and Hormonal Adaptations Following Resistance Training. Nutrients. 9(12):1316.https://doi.org/10.3390/nu9121316CrossRefPubMedPubMedCentral

Nissen S, Sharp R, Ray M, Rathmacher JA, Rice D, Fuller JCJr, Connelly AS, Abumrad N. (1996). Effect of leucine metabolite beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistance-exercise training. J Appl Physiol (1985). 81(5):2095–2104. https://doi.org/10.1152/jappl.1996.8L5.2095CrossRefPubMed

Nissen S. (1997). Measurement of muscle proteolysis and the impact on muscle wasting. Proc Nutr Soc. 56(2):793–799.https://doi.org/10.1079/pns19970080CrossRefPubMed

Deutz NE, Pereira SL, Hays NP, Oliver JS, Edens NK, Evans CM, Wolfe RR.(2013). Effect of β-hydroxy-β-methylbutyrate (HMB) on lean body mass during 10 days of bed rest in older adults. Clin Nutr. 32(5):704–712. https://doi.org/10.1016/j.clnu.2013.02.011CrossRefPubMed

10.

Matheson EM, Nelson JL, Baggs GE, Luo M, Deutz NE. (2021). Specialized oral nutritional supplement (ONS) improves handgrip strength in hospitalized, malnourished older patients with cardiovascular and pulmonary disease: A randomized clinical trial. Clin Nutr. 40(3):844–849. https://doi.org/10.1016/j.clnu.2020.08.035CrossRefPubMed

11.

Engelen MPKJ, Deutz NEP. (2018). Is β-hydroxy β-methylbutyrate an effective anabolic agent to improve outcome in older diseased populations?. Curr Opin Clin Nutr Metab Care. 21(3):207–213. https://doi.org/10.1097/MCO.0000000000000459CrossRefPubMedPubMedCentral

12.

Shreeram S, Ramesh S, Puthan JK, Balakrishnan G, Subramanian R, Reddy MT, Pereira SL. (2016). Age associated decline in the conversion of leucine to β-Hydroxy-β-Methylbutyrate in rats. Exp Gerontol. 80:6–11. https://doi.org/10.1016/j.exger.2016.03.021CrossRefPubMed

13.

Cui D, Drake JC, Wilson RJ, Shute RJ, Lewellen B, Zhang M, Zhao H, Sabik OL, Onengut S, Berr SS, et al. (2020). A novel voluntary weightlifting model in mice promotes muscle adaptation and insulin sensitivity with simultaneous enhancement of autophagy and mTOR pathway. FASEB J. 34(6):7330–7344. https://doi.org/10.1096/fj.201903055RCrossRefPubMed

14.

Silva VR, Belozo FL, Micheletti TO, Conrado M, Stout JR, Pimentel GD, Gonzalez AM. (2017). β-hydroxy-β-methylbutyrate free acid supplementation may improve recovery and muscle adaptations after resistance training: a systematic review. Nutr Res. 45:1–9. https://doi.org/10.1016/j.nutres.2017.07.008CrossRefPubMed

15.

Wu, H., Xia, Y., Jiang, J., Du, H., Guo, X., Liu, X., Li, C., Huang, G., & Niu, K. (2015). Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults: a systematic review and meta-analysis. Archives of gerontology and geriatrics, 61(2), 168–175. https://doi.org/10.1016/j.archger.2015.06.020CrossRefPubMed

16.

Berton, L., Bano, G., Carraro, S., Veronese, N., Pizzato, S., Bolzetta, F., De Rui, M., Valmorbida, E., De Ronch, I., Perissinotto, E., Coin, A., Manzato, E., & Sergi, G. (2015). Effect of Oral Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation on Physical Performance in Healthy Old Women Over 65 Years: An Open Label Randomized Controlled Trial. PloS one, 10(11), e0141757. https://doi.org/10.1371/journal.pone.0141757CrossRefPubMedPubMedCentral

17.

Chew, S., Tan, N. C., Cheong, M., Oliver, J., Baggs, G., Choe, Y., How, C. H., Chow, W. L., Tan, C., Kwan, S. C., Husain, F. S., Low, Y. L., Huynh, D., & Tey, S. L. (2021). Impact of specialized oral nutritional supplement on clinical, nutritional, and functional outcomes: A randomized, placebo-controlled trial in community-dwelling older adults at risk of malnutrition. Clinical nutrition (Edinburgh, Scotland), 40(4), 1879–1892. https://doi.org/10.1016/j.clnu.2020.10.015CrossRefPubMed

18.

Courel-Ibáñez J, Pallares JG; HEAL study group. (2019). Effects of β-hydroxy-β-methylbutyrate(HMB) supplementation in addition to multicomponent exercise in adults older than 70 years living in nursing homes, a cluster randomized placebo-controlled trial: the HEAL study protocol. BMC Geriatr. 19(1):188.https://doi.org/10.1186/s12877-019-1200-5CrossRefPubMedPubMedCentral

19.

Stout, J. R., Smith-Ryan, A. E., Fukuda, D. H., Kendall, K. L., Moon, J. R., Hoffman, J. R., Wilson, J. M., Oliver, J. S., & Mustad, V. A. (2013). Effect of calcium β-hydroxy-β-methylbutyrate (CaHMB) with and without resistance training in men and women 65+yrs: a randomized, double-blind pilot trial. Experimental gerontology, 48(11), 1303–1310. https://doi.org/10.1016/j.exger.2013.08.007CrossRefPubMed

20.

Zhu LY, Chan R, Kwok T, Cheng KC, Ha A, Woo J. (2019). Effects of exercise and nutrition supplementation in community-dwelling older Chinese people with sarcopenia: a randomized controlled trial. Age Ageing. 48(2):220–228. https://doi.org/10.1093/ageing/afy179CrossRefPubMed

21.

Courel-Ibáñez, J., Vetrovsky, T., Dadova, K., Pallares, J. G., & Steffi, M. (2019). Health Benefits of β-Hydroxy-β-Methylbutyrate (HMB) Supplementation in Addition to Physical Exercise in Older Adults: A Systematic Review with Meta-Analysis. Nutrients, 11(9), 2082. https://doi.org/10.3390/nu11092082CrossRefPubMedPubMedCentral

22.

Faul, F., Erdfelder, E., Lang, A. G., & Buchner, A. (2007). G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior research methods, 39(2), 175–191. https://doi.org/10.3758/bf03193146CrossRefPubMed

23.

Swain David P, Brawner Clinton A, American College of Sports Medicine. (2014). ACSM’s Resource Manual for Guidelines for Exercise Testing and Prescription, Wolters Kluwer Health/Lippincott Williams & Wilkins: Philadelphia, Pennsylvania. ISBN: 9781609139568

24.

Kim J. (2021). Handgrip Strength to Predict the Risk of All-Cause and Premature Mortality in Korean Adults: A 10-Year Cohort Study. Int J Environ Res Public Health. 19(1):39. https://doi.org/10.3390/ijerph19010039CrossRefPubMedPubMedCentral

25.

Kaegi-Braun N, Tribolet P, Baumgartner A, Fehr R, Baechli V, Geiser M, Deiss M, Gomes F, Kutz A, Hoess C, et al. (2021). Value of handgrip strength to predict clinical outcomes and therapeutic response in malnourished medical inpatients: Secondary analysis of a randomized controlled trial. Am J Clin Nutr. 114(2):731–740. https://doi.org/10.1093/ajcn/nqab042CrossRefPubMed

26.

Mendes J, Amaral TF, Borges N, Santos A, Padrào P, Moreira P, Afonso C, Negräo R. (2017). Handgrip strength values of Portuguese older adults: a population based study. BMC Geriatr. 17(1):191. https://doi.org/10.1186/s12877-017-0590-5CrossRefPubMedPubMedCentral

27.

Bohannon RW, Bubela DJ, Magasi SR, Wang YC, Gershon RC. (2010). Sit-to-stand test: Performance and determinants across the age-span. Isokinet Exerc Sci. 18(4):235–240. https://doi.org/10.3233/IES-2010-0389CrossRefPubMedPubMedCentral

28.

Lynch NA, Metter EJ, Lindle RS, Fozard JL, Tobin JD, Roy TA, Fleg JL, Hurley BF. (1999). Muscle quality. I. Age-associated differences between arm and leg muscle groups. J Appl Physiol (1985). 86(1):188–194.https://doi.org/10.1152/jappl.1999.86.1.188CrossRefPubMed

29.

Landrum, M. B., & Becker, M. P. (2001). A multiple imputation strategy for incomplete longitudinal data. Statistics in medicine, 20(17–18), 2741–2760. https://doi.org/10.1002/sim.740CrossRefPubMed

30.

Nasimi, N., Sohrabi, Z., Dabbaghmanesh, M. H., Eskandari, M. H., Bedeltavana, A., Famouri, M., & Talezadeh, P. (2021). A Novel Fortified Dairy Product and Sarcopenia Measures in Sarcopenic Older Adults: A Double-Blind Randomized Controlled Trial. Journal of the American Medical Directors Association, 22(4), 809–815. https://doi.org/10.1016/j.jamda.2020.08.035CrossRefPubMed

31.

Osuka Y, Kojima N, Sasai H, Wakaba K, Miyauchi D, Tanaka K, Kim H. (2021). Effects of exercise and/or β-hydroxy-β-methylbutyrate supplementation on muscle mass, muscle strength, and physical performance in older women with low muscle mass: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 114(4):1371–1385.https://doi.org/10.1093/ajcn/nqab176CrossRefPubMed

32.

Nissen, S., Sharp, R., Ray, M., Rathmacher, J. A., Rice, D., Fuller, J. C.,Jr, Connelly, A. S., & Abumrad, N. (1996). Effect of leucine metabolite beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistance-exercise training. Journal of applied physiology (Bethesda, Md.: 1985), 81(5), 2095–2104. https://doi.org/10.1152/jappl.1996.81.5.2095CrossRefPubMed

33.

Malhotra R, Tareque MI, Tan NC, Ma S. (2020). Association of baseline hand grip strength and annual change in hand grip strength with mortality among older people. Arch Gerontol Geriatr. 86:103961. https://doi.org/10.1016/j.archger.2019.103961CrossRefPubMed

34.

Dardevet D, Rémond D, Peyron MA, Papet I, Savary-Auzeloux I, Mosoni L. (2012). Muscle wasting and resistance of muscle anabolism: the ”anabolic threshold concept” for adapted nutritional strategies during sarcopenia. ScientificWorldJournal.2012:269531. https://doi.org/10.1100/2012/269531

35.

Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., Schneider, S. M., Sieber, C. C., Topinkova, E., Vandewoude, M., Visser, M., Zamboni, M., & Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2 (2019). Sarcopenia: revised European consensus on definition and diagnosis. Age and ageing, 48(4), 601. https://doi.org/10.1093/ageing/afz046CrossRefPubMedPubMedCentral

36.

McGregor, R. A., Cameron-Smith, D., & Poppitt, S. D. (2014). It is not just muscle mass: a review of muscle quality, composition and metabolism during ageing as determinants of muscle function and mobility in later life. Longevity & healthspan, 3(1), 9. https://doi.org/10.1186/2046-2395-3-9CrossRef

37.

Barbat-Artigas, S., Rolland, Y., Zamboni, M., & Aubertin-Leheudre, M. (2012). How to assess functional status: a new muscle quality index. The journal of nutrition, health & aging, 16(1), 67–77. https://doi.org/10.1007/s12603-012-0004-5CrossRef

38.

Goldberg, E. L., & Dixit, V. D. (2015). Drivers of age-related inflammation and strategies for healthspan extension. Immunological reviews, 265(1), 63–74. https://doi.org/10.1111/imr.12295CrossRefPubMedPubMedCentral

39.

Li, C. W., Yu, K., Shyh-Chang, N., Li, G. X., Jiang, L. J., Yu, S. L., Xu, L. Y., Liu, R. J., Guo, Z. J., Xie, H. Y., Li, R. R., Ying, J., Li, K., & Li, D. J. (2019). Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention. Journal of cachexia, sarcopenia and muscle, 10(3), 586–600. https://doi.org/10.1002/jcsm.12417CrossRefPubMedPubMedCentral

40.

Yonamine, C. Y., Teixeira, S. S., Campello, R. S., Gerlinger-Romero, F., Rodrigues, C. F., Jr, Guimaräes-Ferreira, L., Machado, U. F., & Nunes, M. T. (2014). Beta hydroxy beta methylbutyrate supplementation impairs peripheral insulin sensitivity in healthy sedentary Wistar rats. Acta physiologica (Oxford, England), 212(1), 62–74. https://doi.org/10.1111/apha.12336CrossRefPubMed

Title: Effects of Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Older Adults with Sarcopenia: A Randomized, Double-Blind, Placebo-Controlled Study
Authors: C. Yang
Y. Song
T. Li
X. Chen
J. Zhou
Q. Pan
W. Jiang
M. Wang
Hong Jia
Publication date: 28-04-2023
Publisher: Springer Paris
Keyword: Sarcopenia
Published in: The journal of nutrition, health & aging / Issue 5/2023
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI: https://doi.org/10.1007/s12603-023-1911-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Design

Setting and Participants

Intervention

Measurements

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2023

Obesity and Accelerated Aging

The Association between Dietary Inflammatory Index and Aging Biomarkers/Conditions: A Systematic Review and Dose-response Meta-analysis

Understanding the Impact of Obesity on Ageing in the Radiance of DNA Metabolism

The Interplay between Systolic Blood Pressure, Sauna Bathing, and Cardiovascular Mortality in Middle-Aged and Older Finnish Men: A Cohort Study

How Neighborhood Structural and Individual Characteristics Affect Frailty Progression: Evidence from the China Health and Retirement Longitudinal Study

Impact of the Comprehensive Awareness Modification of Mouth, Chewing and Meal (CAMCAM) Program on the Attitude and Behavior Towards Oral Health and Eating Habits as Well as the Condition of Oral Frailty: A Pilot Study

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage